Palata, Roshil Jane .
HRN: 06-52-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/12/2025
11/13/2025
IVT
500mg
Q8 X 6 Doses
S/P LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes